Skip to content

PowerFlow AIV14

by Bard Access Systems, Inc.

PowerFlow AIV14 is an apheresis kit (FDA Class II; FDA product code PTD, Subcutaneous implanted apheresis port) made by Bard Access Systems, Inc., listed in FDA GUDID since 5 Jul 2017 (UDI-DI 00801741136634), registry data as of 22 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00801741136634 UDI-DI Date5 Jul 2017ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
PowerFlow IV Port Access System, 14G
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
Labelled as not made with natural rubber latex
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
PowerFlow
Generic name
Apheresis kit
Model / Ref / Catalog
AIV14
Primary DI / UDI-DI
00801741136634
FDA product code
PTD
GMDN term
Apheresis kit
Device class
Class II
Regulation number
880.5965
GUDID distribution status
In Commercial Distribution
Size
Needle Gauge — 14 Gauge
Length — 1.75 Inch

Similar devices

Other devices filed under FDA product code PTD (Subcutaneous implanted apheresis port).

Other devices from Bard Access Systems, Inc.

See all devices from Bard Access Systems, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Prescription use
  • Convenience kit
  • Combination product
  • Lot / batch number
  • Expiration date
Other properties (8, all answered No)